Sale of Securities

Tyra Biosciences, Inc. Filed 2025-11-13 Acc 0001628280-25-052140

Documents 1

2025-11-17 144 Sale of Securities
2025-11-17 4 Chief Operating Officer sold 131,411 shares at an average $16.04 ($2,108,067)
2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-14 144 Sale of Securities
2025-11-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-11-13 144 Sale of Securities
2025-06-18 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…